GENNEX LABORATORIES
Back to Cashflow Statement
|
GENNEX LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹65 Cr | ₹4.57 Cr | ₹74 Cr | ₹21 Cr | ₹-1.83 Cr |
What is the latest Cash Flow from Financing Activities ratio of GENNEX LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹65 Cr |
| Mar2025 | ₹4.57 Cr |
| Mar2024 | ₹74 Cr |
| Mar2023 | ₹21 Cr |
| Mar2022 | ₹-1.83 Cr |
How is Cash Flow from Financing Activities of GENNEX LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹65 Cr | 1,329.87 | |
| Mar2025 | ₹4.57 Cr | -93.80 | |
| Mar2024 | ₹74 Cr | 250.33 | |
| Mar2023 | ₹21 Cr | Positive | |
| Mar2022 | ₹-1.83 Cr | - | |
Compare Cash Flow from Financing Activities of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹220.3 Cr | 1.2% | -2.3% | -39.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,944.0 Cr | -2% | 6% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,962.0 Cr | -4% | 22.9% | 75.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,391.0 Cr | -1.8% | 1.8% | 21.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,267.0 Cr | -0.4% | 13.1% | 13.7% | Stock Analytics | |
| CIPLA | ₹112,620.0 Cr | -0.9% | 4.5% | -8% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | 1.2% |
-2.3% |
-39.8% |
| SENSEX | 1.4% |
12.8% |
-1.7% |
You may also like the below Video Courses